Elevated transaminase levels themselves are not contagious, but certain diseases that cause elevated transaminase levels may be contagious. Elevated transaminase levels may be related to factors such as viral hepatitis, fatty liver, and drug-induced liver injury. It is recommended to seek medical attention promptly to determine the cause.
Viral hepatitis is a common infectious disease that causes elevated transaminase levels. Hepatitis A and E are mainly transmitted through fecal oral route, while hepatitis B and C are transmitted through blood, mother to child or sexual contact. These patients need to be isolated for treatment and avoid sharing personal items such as toothbrushes and razors with others. The elevation of transaminase caused by viral hepatitis requires antiviral treatment, commonly used drugs include entecavir tablets, propafenone fumarate and tenofovir tablets, etc. Non communicable diseases such as fatty liver, alcoholic liver disease, or autoimmune hepatitis can also lead to elevated transaminase levels. Long term high-fat diet, alcohol abuse, or metabolic abnormalities may induce fatty liver, manifested as fatigue and discomfort in the upper right abdomen. These patients need to adjust their lifestyle, limit alcohol intake, and control their weight. Drug induced liver injury is often caused by antibiotics, anti tuberculosis drugs, etc. After discontinuing medication, transaminase levels usually gradually recover. If high transaminase levels are found, excessive fatigue and alcohol consumption should be avoided, and a light diet should be maintained. Suggest increasing the intake of fresh vegetables and fruits, and supplementing high-quality protein such as fish and soy products appropriately. Regularly review liver function indicators, and seek medical attention immediately if accompanied by symptoms such as jaundice and abdominal distension. Depending on the cause, doctors may recommend liver protection treatments such as compound glycyrrhizin tablets, silibinin capsules, and other medications.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!